These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26134178)

  • 1. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors.
    Manuel ER; Chen J; D'Apuzzo M; Lampa MG; Kaltcheva TI; Thompson CB; Ludwig T; Chung V; Diamond DJ
    Cancer Immunol Res; 2015 Sep; 3(9):1096-107. PubMed ID: 26134178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth.
    Phan T; Nguyen VH; D'Alincourt MS; Manuel ER; Kaltcheva T; Tsai W; Blazar BR; Diamond DJ; Melstrom LG
    Cancer Gene Ther; 2020 Apr; 27(3-4):235-245. PubMed ID: 30824815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.
    Blache CA; Manuel ER; Kaltcheva TI; Wong AN; Ellenhorn JD; Blazar BR; Diamond DJ
    Cancer Res; 2012 Dec; 72(24):6447-56. PubMed ID: 23090116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.
    Blair AB; Kim VM; Muth ST; Saung MT; Lokker N; Blouw B; Armstrong TD; Jaffee EM; Tsujikawa T; Coussens LM; He J; Burkhart RA; Wolfgang CL; Zheng L
    Clin Cancer Res; 2019 Sep; 25(17):5351-5363. PubMed ID: 31186314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.
    Blair AB; Kleponis J; Thomas DL; Muth ST; Murphy AG; Kim V; Zheng L
    J Clin Invest; 2019 Apr; 129(4):1742-1755. PubMed ID: 30747725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of Tumor Infiltrating γδ T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppressor, 4-Methylumbelliferone.
    Suto A; Kudo D; Yoshida E; Nagase H; Suto S; Mimura J; Itoh K; Hakamada K
    Pancreas; 2019 Feb; 48(2):292-298. PubMed ID: 30589828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.
    Zhen DB; Coveler A; Zanon S; Reni M; Chiorean EG
    Semin Oncol; 2018 Jun; 45(3):107-115. PubMed ID: 30391013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.
    Jonescheit H; Oberg HH; Gonnermann D; Hermes M; Sulaj V; Peters C; Kabelitz D; Wesch D
    Cells; 2020 May; 9(5):. PubMed ID: 32384638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.
    Garrido-Laguna I; Hidalgo M
    Nat Rev Clin Oncol; 2015 Jun; 12(6):319-34. PubMed ID: 25824606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
    Wong KM; Horton KJ; Coveler AL; Hingorani SR; Harris WP
    Curr Oncol Rep; 2017 Jul; 19(7):47. PubMed ID: 28589527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1
    Cortese N; Capretti G; Barbagallo M; Rigamonti A; Takis PG; Castino GF; Vignali D; Maggi G; Gavazzi F; Ridolfi C; Nappo G; Donisi G; Erreni M; Avigni R; Rahal D; Spaggiari P; Roncalli M; Cappello P; Novelli F; Monti P; Zerbi A; Allavena P; Mantovani A; Marchesi F
    Cancer Immunol Res; 2020 Apr; 8(4):493-505. PubMed ID: 32019781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors.
    Gaida MM; Steffen TG; Günther F; Tschaharganeh DF; Felix K; Bergmann F; Schirmacher P; Hänsch GM
    Eur J Immunol; 2012 Dec; 42(12):3369-80. PubMed ID: 23001948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.
    Lu J; Liu X; Liao YP; Salazar F; Sun B; Jiang W; Chang CH; Jiang J; Wang X; Wu AM; Meng H; Nel AE
    Nat Commun; 2017 Nov; 8(1):1811. PubMed ID: 29180759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3+ regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
    Kobayashi N; Kubota K; Kato S; Watanabe S; Shimamura T; Kirikoshi H; Saito S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A
    Pancreatology; 2010; 10(5):631-40. PubMed ID: 21051918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
    Zhang Y; Feng Y; Huang Y; Wang Y; Qiu L; Liu Y; Peng S; Li R; Kuang N; Shi Q; Shi Y; Chen Y; Joshi R; Wang Z; Yuan K; Min W
    Front Immunol; 2020; 11():968. PubMed ID: 32582152
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
    Provenzano PP; Cuevas C; Chang AE; Goel VK; Von Hoff DD; Hingorani SR
    Cancer Cell; 2012 Mar; 21(3):418-29. PubMed ID: 22439937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronidase-Expressing
    Ebelt ND; Zuniga E; Passi KB; Sobocinski LJ; Manuel ER
    Mol Cancer Ther; 2020 Feb; 19(2):706-716. PubMed ID: 31694889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.
    Balachandran VP; Beatty GL; Dougan SK
    Gastroenterology; 2019 May; 156(7):2056-2072. PubMed ID: 30660727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.